Wegovy’s So-Called “Long-Term” Study
May 27, 2023•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Today we are breaking down Novo Nordisk's 2-year study of their weight loss drug, Wegovy. I want to thank Deb Burgard for her help with this piece. She is quoted and was kind enough to review and give feedback on the piece and I am incredibly grateful!
Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe
For the best experience, listen in Metacast app for iOS or Android